Find the investors funding AI rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Boltz raises $110 million as weekly use of its AI drug design models rises about 50-fold - MLQ.ai
Boltz is an AI company focused on drug design. The company has raised $110 million, indicating significant investor confidence in its AI-driven approach to pharmaceutical development. Weekly usage of its AI drug design models has seen a substantial increase, suggesting strong market adoption and validation of its technology.
Boltz raises $110 million as weekly use of its AI drug design models rises about 50-fold MLQ.ai
| Nov 19, 2026 | Stryx AI | $8.3M | Seed | — |
| Nov 18, 2026 | Perry AI | $2.2M | Seed | — |
| Nov 18, 2026 | Caper AI | $13.0M | — | — |
| Nov 18, 2026 | Zhiye Technology | $4.5M | Series A | — |
You just read who funded Boltz. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.